ArticleHaematologica2024

Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia.

Matthew P Connor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.